PCL, Inc. engages in the manufacturing of medical devices. Its products include Blood Testing Kit-Hi3, Ai, Cancer6, SolB Reagent, SolB Desktop Arrayer, and sciFLEXARRAYER. It also offers SG Cap Drug Target ID Service and Sol-Gel Spotting Service. The company was founded on February 12, 2008 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company